Labcorp Holdings Inc.
LH- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000920148
In the last 90 days, Labcorp Holdings Inc. insiders filed 0 open-market purchases and 6 sales; 1,061 institutions reported holding it in 13F filings for Q2 2026, worth $22.2B in total; Weitz Investment Management is the only superinvestor holding it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $3.27M in total
- 6
- 13F holdersQ2 2026, +34 vs. previous quarter
- 1,061
- 13F valueReported value at the end of Q2 2026
- $22.2B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding LH, Q2 2026
1 superinvestor reports holding Labcorp Holdings Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Weitz Investment Management
Wally Weitz
1.9%
Labcorp Holdings Inc.'s share of the portfolio
- Shares
- 99,050
- Value
- $27.7M
Latest insider trades
Open-market purchases and sales by Labcorp Holdings Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)8:10 AM ET | Aug 17 | 1 day | Anderson Kerrii BDirector | SSale | −3.00K | $318.02 | −$954.1K | −31.4%6.56K after | 10b5-1 |
| Aug 12, 2026 (view filing)2:31 PM ET | Aug 11 | 1 day | Schechter Adam HPresident & CEO | SSale | −4.67K | $320.37 | −$1.50M | −4.4%102.6K after | 10b5-1 |
| Aug 6, 2026 (view filing)8:26 AM ET | Aug 4 | 2 days | Summy Amy B.EVP, Chief Marketing Officer | SSale | −924 | $306.74 | −$283.4K | −11.7%6.96K after | |
| Aug 5, 2026 (view filing)11:17 AM ET | Aug 3 | 2 days | Wilkinson Peter JSVP, Chief Accounting Officer | SSale | −1.42K | $309.23 | −$439.1K | −44.5%1.77K after | 2 lots |
| Jul 6, 2026 (view filing)9:37 AM ET | Jul 2 | 4 days | Kyle Kathryn WEVP, Chief Legal Officer | SSale | −92 | $286.19 | −$26.3K | −2.3%3.90K after | 10b5-1 |
| Jul 6, 2026 (view filing)9:36 AM ET | Jul 2 | 4 days | Vaughn Bryan TEVP and President, Diagnostics | SSale | −234 | $286.19 | −$67.0K | −3.4%6.75K after | 10b5-1 |
| Jun 10, 2026 (view filing) | Jun 8 | 2 days | Kyle Kathryn WEVP, Chief Legal Officer | SSale | −762 | $263.89 | −$201.1K | −16.7%3.81K after | 10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Schechter Adam HPresident & CEO | SSale | −5.90K | $254.50 | −$1.50M | −5.2%107.2K after | 10b5-1 |
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Wilkinson Peter JSVP, Chief Accounting Officer | SSale | −1.63K | $267.05 | −$436.1K | −46.9%1.85K after | 10b5-1 |
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Meltzer Jonathan CEVP, Operations | SSale | −839 | $267.05 | −$224.1K | −18.8%3.62K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Labcorp Holdings Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,574,261 | $1.84B | 0.03% | +129,405+2.0% | Added |
| Vanguard Capital Management LLC | 5,362,254 | $1.50B | 0.03% | −13,866−0.3% | Reduced |
| Victory Capital Management Inc | 4,837,573 | $1.35B | 0.76% | +210,447+4.5% | Added |
| State Street Corp | 3,907,656 | $1.09B | 0.03% | +44,485+1.2% | Added |
| Vanguard Portfolio Management LLC | 3,678,798 | $1.03B | 0.05% | −1,863−0.1% | Reduced |
| Boston Partners | 3,051,690 | $854.2M | 0.76% | +682,894+28.8% | Added |
| Allspring Global Investments Holdings, LLC | 2,236,957 | $635.0M | 0.97% | +10,511+0.5% | Added |
| Geode Capital Management, LLC | 2,188,890 | $610.4M | 0.03% | +2,948+0.1% | Added |
| Select Equity Group, L.P. | 1,981,948 | $554.9M | 2.94% | −192,837−8.9% | Reduced |
| FMR LLC | 1,904,870 | $533.4M | 0.02% | +616,459+47.8% | Added |